05/13/2025
6:10 AM | Leap Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/13/2025
5:51 AM | Leap Therapeutics (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
04/25/2025
7:52 PM | Leap Therapeutics (Filer)
| Form DEF 14A | |
04/25/2025
7:54 PM | Leap Therapeutics (Filer)
| Form DEFA14A | |
04/25/2025
7:55 PM | Leap Therapeutics (Filer)
| Form ARS | |
04/01/2025
8:51 PM | Leap Therapeutics (Issuer)
Sirard Cynthia (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/01/2025
8:51 PM | Leap Therapeutics (Issuer)
Mirabelli Christopher (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/01/2025
8:52 PM | Leap Therapeutics (Issuer)
O'Mahony John Mark (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/01/2025
8:53 PM | LAWLOR AUGUSTINE (Reporting)
Leap Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/01/2025
8:53 PM | Baum Jason (Reporting)
Leap Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/01/2025
8:54 PM | Granfield Christine (Reporting)
Leap Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
Get the Latest News and Ratings for LPTX and Related Stocks Enter your email address below to receive the latest news and analysts' ratings for Leap Therapeutics and its competitors with MarketBeat's FREE daily newsletter. |
04/01/2025
8:55 PM | Leap Therapeutics (Issuer)
ONSI DOUGLAS E (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/26/2025
4:01 PM | Leap Therapeutics (Filer)
| Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans | |
03/26/2025
6:15 AM | Leap Therapeutics (Filer)
| Form 10-K
Annual report pursuant to Section 13 or 15(d) | |
03/26/2025
6:10 AM | Leap Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
03/17/2025
3:30 PM | Leap Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
02/14/2025
5:22 AM | BALYASNY ASSET MANAGEMENT L.P. (Filed by)
Leap Therapeutics (Subject)
| Form SCHEDULE 13G/A | |
01/28/2025
7:00 AM | Leap Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
11/15/2024
4:28 PM | Leap Therapeutics (Issuer)
Mirabelli Christopher (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/15/2024
4:29 PM | LAWLOR AUGUSTINE (Reporting)
Leap Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/15/2024
4:30 PM | Leap Therapeutics (Issuer)
ONSI DOUGLAS E (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/15/2024
4:31 PM | CAVANAUGH JAMES H (Reporting)
Leap Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/14/2024
5:07 AM | BALYASNY ASSET MANAGEMENT L.P. (Filed by)
Leap Therapeutics (Subject)
| Form SC 13G | |
11/13/2024
6:10 AM | Leap Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
11/13/2024
5:50 AM | Leap Therapeutics (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
10/31/2024
5:29 PM | BeiGene, Ltd. (Filed by)
BeiGene, Ltd. (Filed by)
Leap Therapeutics (Subject)
| Form SC 13D/A | |
10/31/2024
4:40 PM | BeiGene, Ltd. (Filed by)
BeiGene, Ltd. (Filed by)
Leap Therapeutics (Subject)
| Form SCHEDULE 13D/A | |
10/04/2024
4:22 PM | Leap Therapeutics (Issuer)
Mashiach Nissim (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
10/04/2024
4:23 PM | Baum Jason (Reporting)
Leap Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
10/04/2024
4:23 PM | Leap Therapeutics (Issuer)
Mirabelli Christopher (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
10/04/2024
4:23 PM | CAVANAUGH JAMES H (Reporting)
Leap Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
10/04/2024
4:24 PM | Dietz Thomas John (Reporting)
Leap Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
10/04/2024
4:24 PM | LAWLOR AUGUSTINE (Reporting)
Leap Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
10/04/2024
4:24 PM | Leap Therapeutics (Issuer)
O'Mahony John Mark (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
10/04/2024
4:24 PM | Leap Therapeutics (Issuer)
LI WILLIAM (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
10/04/2024
4:25 PM | Leap Therapeutics (Issuer)
LOSCALZO JOSEPH (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
10/04/2024
4:25 PM | Leap Therapeutics (Issuer)
ONSI DOUGLAS E (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
10/04/2024
4:25 PM | Leap Therapeutics (Issuer)
Martin Patricia A. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
10/04/2024
4:26 PM | Leap Therapeutics (Issuer)
Richard Christian M (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
10/04/2024
4:27 PM | Leap Therapeutics (Issuer)
Schilsky Richard (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
10/04/2024
4:29 PM | Leap Therapeutics (Issuer)
Sirard Cynthia (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
Watch This Robotics Demo Before July 23rd (Ad) Jeff Brown, the tech legend who picked shares of Nvidia in 2016 before they jumped by more than 22,000%...
Just did a demo of what Nvidia’s CEO said will be "the first multitrillion-dollar robotics industry." Click here to watch the demo… |
10/04/2024
4:29 PM | Granfield Christine (Reporting)
Leap Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/30/2024
6:30 AM | Leap Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
08/12/2024
6:10 AM | Leap Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
08/12/2024
5:50 AM | Leap Therapeutics (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
07/08/2024
3:48 PM | Leap Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
Buy LPTX Stock Free LPTX Stock Alerts